Skip to main content
. 2017 Sep 21;12(9):e0184173. doi: 10.1371/journal.pone.0184173

Fig 1. Cumulative incidence curves for cancer-specific mortality.

Fig 1

A) Non-metastatic disease, papillary renal cell carcinoma (pRCC) versus clear cell renal cell carcinoma (ccRCC); B) Non-metastatic disease, pRCC subtypes (type 1 and type 2) versus ccRCC; C) Metastatic disease, pRCC versus ccRCC; D) Metastatic disease, pRCC subtypes (type 1 and type 2) versus ccRCC.